FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2131138289> ?p ?o ?g. }

• W2131138289 endingPage "2736" @default.
• W2131138289 startingPage "2723" @default.
• W2131138289 abstract "This prospective, nonrandomized trial evaluated a percutaneous isolated chemotherapy perfusion approach for treating advanced primary and metastatic liver tumors. Chemotherapy was administered via hepatic artery catheter and hepatic venous blood isolated by a novel percutaneous double-balloon inferior vena cava (IVC) catheter was passed through a detoxification/filtration cartridge in a venovenous bypass circuit.Among 23 patients enrolled onto the study, 58 procedures were performed on 21 patients. Twelve patients received dose escalations of fluorouracil (5-FU) (1,000 mg/m2 to 5,000 mg/m2), and nine received dose escalations of doxorubicin (50 mg/m2 to 120 mg/m2). Pharmacokinetic studies included drug accumulation in the liver, extraction by detoxification filters, systemic exposure, and alterations of half-life. Each patient received two treatments at 3-week intervals. Those showing stabilization or response received additional treatments.There was a direct relationship between dose and peak concentration of drug entering the hepatic veins. The system functioned efficiently throughout the dose range, with extraction efficiencies ranging from 64% to 91% (P < .001). The hepatic vein drug levels showed a sixfold increase in 5-FU with dose escalation from 1,000 to 5,000 mg/m2, and a twofold increase in dox with dose escalation from 50 to 120 mg/m2 (P < .001, filter-mediated drug extraction). The treatments were accomplished with only an overnight hospital stay and no mortality. The common procedure-related toxicity was transient hypotension (grade I to II), due to catecholamine depletion by the filter. Dose-limiting toxicity (leukopenia) was observed in patients receiving 5-FU at a dose of 5,000 mg/m2 and doxorubicin at a dose of 120 mg/m2. Significant tumor response (> 95% reduction) was obtained in two patients receiving doxorubicin at 90 mg/m2 and 120 mg/m2.The use of a double-balloon catheter to isolate and detoxify hepatic venous blood during intraarterial therapy is technically feasible, safe, and allows administration of large doses of intrahepatic chemotherapy at short intervals. This approach should allow new dose-intensification strategies to increase tumor responses in primary and metastatic liver tumors." @default.
• W2131138289 created "2016-06-24" @default.
• W2131138289 creator A5000610096 @default.
• W2131138289 creator A5005092619 @default.
• W2131138289 creator A5016722881 @default.
• W2131138289 creator A5019788466 @default.
• W2131138289 creator A5040773615 @default.
• W2131138289 creator A5068715826 @default.
• W2131138289 creator A5072709443 @default.
• W2131138289 creator A5077588360 @default.
• W2131138289 creator A5087298598 @default.
• W2131138289 date "1994-12-01" @default.
• W2131138289 modified "2023-09-23" @default.
• W2131138289 title "Percutaneous hepatic vein isolation and high-dose hepatic arterial infusion chemotherapy for unresectable liver tumors." @default.
• W2131138289 cites W1488571428 @default.
• W2131138289 cites W1532113135 @default.
• W2131138289 cites W1825866300 @default.
• W2131138289 cites W1848090478 @default.
• W2131138289 cites W1967594023 @default.
• W2131138289 cites W1986924507 @default.
• W2131138289 cites W2008263511 @default.
• W2131138289 cites W2013313438 @default.
• W2131138289 cites W2028269517 @default.
• W2131138289 cites W2033005592 @default.
• W2131138289 cites W2042854246 @default.
• W2131138289 cites W2044224410 @default.
• W2131138289 cites W2067360588 @default.
• W2131138289 cites W2075962633 @default.
• W2131138289 cites W2079088649 @default.
• W2131138289 cites W2122364701 @default.
• W2131138289 cites W2128813634 @default.
• W2131138289 cites W2132159119 @default.
• W2131138289 cites W2154659963 @default.
• W2131138289 cites W2404629807 @default.
• W2131138289 cites W2408291968 @default.
• W2131138289 cites W2411114264 @default.
• W2131138289 cites W2413799770 @default.
• W2131138289 cites W2416549757 @default.
• W2131138289 cites W2467811085 @default.
• W2131138289 doi "https://doi.org/10.1200/jco.1994.12.12.2723" @default.
• W2131138289 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/7989950" @default.
• W2131138289 hasPublicationYear "1994" @default.
• W2131138289 type Work @default.
• W2131138289 sameAs 2131138289 @default.
• W2131138289 citedByCount "74" @default.
• W2131138289 countsByYear W21311382892012 @default.
• W2131138289 countsByYear W21311382892013 @default.
• W2131138289 countsByYear W21311382892014 @default.
• W2131138289 countsByYear W21311382892015 @default.
• W2131138289 countsByYear W21311382892016 @default.
• W2131138289 countsByYear W21311382892017 @default.
• W2131138289 countsByYear W21311382892018 @default.
• W2131138289 countsByYear W21311382892019 @default.
• W2131138289 countsByYear W21311382892021 @default.
• W2131138289 crossrefType "journal-article" @default.
• W2131138289 hasAuthorship W2131138289A5000610096 @default.
• W2131138289 hasAuthorship W2131138289A5005092619 @default.
• W2131138289 hasAuthorship W2131138289A5016722881 @default.
• W2131138289 hasAuthorship W2131138289A5019788466 @default.
• W2131138289 hasAuthorship W2131138289A5040773615 @default.
• W2131138289 hasAuthorship W2131138289A5068715826 @default.
• W2131138289 hasAuthorship W2131138289A5072709443 @default.
• W2131138289 hasAuthorship W2131138289A5077588360 @default.
• W2131138289 hasAuthorship W2131138289A5087298598 @default.
• W2131138289 hasConcept C126322002 @default.
• W2131138289 hasConcept C141071460 @default.
• W2131138289 hasConcept C2776694085 @default.
• W2131138289 hasConcept C2780813298 @default.
• W2131138289 hasConcept C2910216633 @default.
• W2131138289 hasConcept C29730261 @default.
• W2131138289 hasConcept C71924100 @default.
• W2131138289 hasConceptScore W2131138289C126322002 @default.
• W2131138289 hasConceptScore W2131138289C141071460 @default.
• W2131138289 hasConceptScore W2131138289C2776694085 @default.
• W2131138289 hasConceptScore W2131138289C2780813298 @default.
• W2131138289 hasConceptScore W2131138289C2910216633 @default.
• W2131138289 hasConceptScore W2131138289C29730261 @default.
• W2131138289 hasConceptScore W2131138289C71924100 @default.
• W2131138289 hasIssue "12" @default.
• W2131138289 hasLocation W21311382891 @default.
• W2131138289 hasLocation W21311382892 @default.
• W2131138289 hasOpenAccess W2131138289 @default.
• W2131138289 hasPrimaryLocation W21311382891 @default.
• W2131138289 hasRelatedWork W2003938723 @default.
• W2131138289 hasRelatedWork W2047967234 @default.
• W2131138289 hasRelatedWork W2118496982 @default.
• W2131138289 hasRelatedWork W2137048490 @default.
• W2131138289 hasRelatedWork W2376313638 @default.
• W2131138289 hasRelatedWork W2376445419 @default.
• W2131138289 hasRelatedWork W2395600221 @default.
• W2131138289 hasRelatedWork W2439875401 @default.
• W2131138289 hasRelatedWork W4238867864 @default.
• W2131138289 hasRelatedWork W2525756941 @default.
• W2131138289 hasVolume "12" @default.
• W2131138289 isParatext "false" @default.
• W2131138289 isRetracted "false" @default.
• W2131138289 magId "2131138289" @default.
• W2131138289 workType "article" @default.